Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
8/27/2021
Lynk Pharma Completes $50M Series B Financing
8/27/2021
Innovent and Bolt Bio Collaborate for Three New Oncology Boltbody ISAC...
8/27/2021
Laekna Receives IND Approvals in China and US for Phase Ib/III Global ...
8/27/2021
CDE Issues Three Guidance Documents on Non-clinical Research of Nanome...
8/27/2021
NMPA Withdraws Approvals of 46 Domestic and Foreign Drug Products
8/27/2021
Recent Executive Moves
8/27/2021
Chinese Patent Linkage, Patent Term Adjustment, and Patent Term Extens...
8/26/2021
BeyondSpring Announces Exclusive Deal with Jiangsu Hengrui Pharma for ...
8/25/2021
CDE Solicits Comments on the Technical Guidance for Human Bioavailabil...
8/25/2021
IQVIA: Chinese Hospital Drug Market Rose 14.2% in MAT Q2/2021
8/25/2021
NMPA and SASTIND Issue Notice for Improving Approval and Regulation of...
8/25/2021
China Penalizes NCPC for Failing to Fulfill VBP Supply Contracts
8/25/2021
Alphamab and CSPC Enter Licensing Deal on Anti-HER2 bsAntibody KN026 i...
8/24/2021
HebaBiz Biotech's Anti-cancer Candidate Siroquine Gains IND Approval i...
8/24/2021
NHC Solicits Comments on the Draft Working Procedures for Adjustment o...
8/24/2021
CDE Solicits Comments on the Technical Guidance for Food Impacts in Ne...
8/24/2021
CDE Solicits Comments on the Technical Guidance for Clinical Pharmacok...
8/24/2021
NMPA Announces Package Insert Revision of Oxaliplatin Formulations
8/24/2021
NMPA Announces Package Insert Revision of Propylthiouracil Formulation...
8/24/2021
Review of Top Ten Overseas Out-licensing Deals of Domestic Phama Compa...
8/24/2021
IQVIA: Overall Chinese Pharma Market Growth down 7.9% in 2020
8/24/2021
New Developments in China's Drug Change Management Regulations
8/23/2021
China Passes the Physicians Law of PRC to Protect Rights of Doctors
8/23/2021
Sino Biological Raises $772 Million in Shenzhen ChiNext IPO
8/23/2021
Antengene Approved fpr Phase II Study of Selinexor for Myelofibrosis i...
8/23/2021
BeiGene Announces Acceptance of a sBLA in China for Tislelizumab in Na...
8/23/2021
Roche and KeChow Partner to Commercialize Zelboraf (vemurafenib) in Ch...
8/23/2021
Lonza Expands Guangzhou Manufacturing Facility with a Fill-finish Line
8/23/2021
China Passes New Data Privacy and Security Laws
8/23/2021
BioDuro-Sundia Acquires US-based Phase III/Commercial Drug Product Man...
Page:
172
/
774
Total number of articles:
23207
:
[First]
[<<]
[170]
[171]
[172]
[173]
[174]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit